Broadfoot Jill Marie

SEC CIK: 0001305178

SEC filings (opens in a new tab)

In the past year, 1 open-market sale filing worth $1.53K and no purchases.

Current role at each company

TLPH Talphera, Inc.Directoras of Jun 24, 2026
ATYR aTYR PHARMA INCChief Financial Officeras of Feb 4, 2026
CUE Cue Biopharma, Inc.Directoras of Jan 6, 2026
OTIC Otonomy, Inc.Directoras of Jun 23, 2022

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $1.53K; 1 filing
Net: −$1.53K; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Broadfoot Jill Marie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

ATYR aTYR PHARMA INC

Chief Financial Officer6 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change
Feb 4, 2026 (view filing)	Feb 4	Same day	Broadfoot Jill MarieChief Financial Officer	SSale	−1.56K	$0.98	−$1.53K	−4.0%37.3K after
Feb 4, 2025 (view filing)	Feb 4	Same day	Broadfoot Jill MarieChief Financial Officer	SSale	−1.25K	$3.78	−$4.74K	−3.8%31.8K after
Jun 3, 2024 (view filing)	May 31	3 days	Broadfoot Jill MarieChief Financial Officer	PPurchase	+5.00K	$1.79	+$8.95K	+21.8%28.0K after
Feb 6, 2024 (view filing)	Feb 6	Same day	Broadfoot Jill MarieChief Financial Officer	SSale	−1.59K	$1.69	−$2.69K	−7.1%20.8K after
Feb 6, 2023 (view filing)	Feb 6	Same day	Broadfoot Jill MarieChief Financial Officer	SSale	−1.57K	$2.36	−$3.70K	−9.2%15.5K after
Jan 18, 2022 (view filing)	Jan 13	5 days	Broadfoot Jill MarieChief Financial Officer	PPurchase	+1.92K	$6.75	+$13.0K	+18.9%12.1K after